Letter from Malaysia
Respirology
.
2021 Jun;26(6):624-626.
doi: 10.1111/resp.14057.
Epub 2021 Apr 11.
Authors
Syazatul Syakirin Sirol Aflah
1
,
Alif Adlan Mohd Thabit
2
,
Suresh Kumar Chidambaram
2
Affiliations
1
Respiratory Department, Institute of Respiratory Medicine, Kuala Lumpur, Malaysia.
2
Infectious Disease Department, Sungai Buloh Hospital, Sungai Buloh, Malaysia.
PMID:
33843115
DOI:
10.1111/resp.14057
No abstract available
Keywords:
COVID-19; Malaysia; SARS-CoV-2.
Publication types
Letter
Comment
MeSH terms
Antiviral Agents
COVID-19*
Humans
Malaysia / epidemiology
SARS-CoV-2
World Health Organization
Substances
Antiviral Agents